Find Academic Supervisors

Margherita CantornaView profile

Professor

• Molecular Immunology
• Vitamin D in Immune Regulation
• Inflammatory Bowel Disease (IBD)
• +4 more

Dr. Margherita Cantorna is a Distinguished Professor of Molecular Immunology at the Department of Veterinary and Biomedical Sciences , Pennsylvania State University, and serves as Director of the Center for Molecular Immunology and Infectious Disease . She is affiliated with the Huck Institutes of the Life Sciences and leads a research program at the intersection of nutrition and immune function. Specializes in vitamin D and A's roles in immune regulation Focuses on autoimmune diseases like Inflammatory Bowel Disease (IBD) and Multiple Sclerosis (MS) Investigates gut microbiota interactions with dietary components Research Highlights: Her work demonstrates that developmental vitamin D deficiency exacerbates autoimmune disease susceptibility, with key findings in T cell differentiation , innate lymphoid cell function , and microbiome modulation . Recent publications span topics from vitamin D receptor signaling in hematopoiesis to nutritional strategies for infectious disease resistance . Developed novel VDR reporter mouse models Identified critical roles for vitamin D in IL-22 production and pathogen clearance Explored dietary fiber and mushroom impacts on gut immunity Lab Members: Includes graduate student Juhi Arora and collaborates with researchers across immunology, microbiology, and nutritional sciences. The Cantorna Lab employs cutting-edge transcriptomics and germ-free animal models to dissect diet-immune interactions.

Caitlin DreisbachView profile

Assistant Professor

• Women's Health
• Pregnancy and Obstetrics
• Data Science in Nursing
• +3 more

Caitlin Dreisbach, PhD, RN is an Assistant Professor at the University of Rochester School of Nursing with a dual affiliation at the Goergen Institute for Data Science. She maintains active clinical practice on the high-risk obstetrics unit at Strong Memorial Hospital while leading interdisciplinary research at the intersection of nursing science and data analytics. Her educational background includes a PhD in Nursing from the University of Virginia (2020), BSN from Johns Hopkins University (2013), and undergraduate studies at Cornell University. Her research interests span women's lifelong health trajectories , quantitative clinical assessment during pregnancy , microbiome dynamics , and social determinants of health in reproductive outcomes. She employs advanced data science techniques including natural language processing, machine learning, and microbiome analysis to address complex questions in maternal-child health. Analysis of her 15 most recent publications reveals a strong focus on leveraging large-scale datasets (particularly the All of Us Research Program) to investigate pregnancy outcomes, symptom science, and chronic disease patterns. Key methodological themes include predictive modeling of birth outcomes, extraction of clinical data from unstructured notes, and analysis of microbiome-diet interactions during gestation. Scientific awards and recognition include: Josephine Craytor Nurse Faculty Award (2024) Most Promising New Investigator (2023) Phyllis J. Verhonick Dissertation Award (2020) Wood Family Award for Data Science (2018) The Raven Society membership (2017) Dr. Dreisbach serves as Principal Investigator for multiple funded projects including an NIH/NINR grant on neural network approaches to fetal weight estimation (2022-2025) and a Heilbrunn Foundation grant examining surgical weight management before pregnancy (2024-2026). Her lab (DreisbachLab) develops open-source tools for reproductive health research, including the GAP_Projection repository for birthweight prediction algorithms. She also contributes as a data science consultant on projects like the Significance of Symptom Onset-To-Angiography Time study at CTSI. Her work bridges clinical practice, data science innovation, and nursing education through initiatives advancing data competencies for PhD students and exploring implications of generative AI in nursing science.

• Neonatology
• Pediatric Health
• Nutritional Science
• +3 more

Dr. Fordjour Lawrence is a Clinical Assistant Professor at SUNY Downstate Medical Center in Brooklyn, New York, affiliated with the Department of Pediatrics. He serves as the Director of the High-Risk Neurodevelopmental NICU Follow-up Clinic and Associate Program Director of the Pediatric Residency Program. Education: Danylo Halytsky Lviv National Medical University, Ukraine; Internship and Residency at Long Island College Hospital/Beth Israel Medical Center; Fellowship at New York University. Dr. Lawrence’s research focuses on neonatal nutrition, gut immunology in preterm newborns, maternal and neonatal obesity, gestational diabetes effects on outcomes, and neurodevelopmental outcomes of preterm babies. He also leads global health initiatives to improve neonatal care in low- and middle-income countries. His recent publications explore adverse outcomes linked to maternal obesity in inner-city populations, competency goals for residents, and antibiotic effects on gut-derived short-chain fatty acids in translational models.

• Nephrology
• Biomineralization
• Health Informatics
• +3 more

Jessica Saw serves as a Teaching Professor at the Carle Illinois College of Medicine, University of Illinois Urbana-Champaign, where she directs the Renal program within Biomedical and Translational Sciences. Her instructional responsibilities include teaching Renal (BSE 633) and Human Anatomy & Physiology Laboratory courses (MCB 245/247), emphasizing hands-on medical education for future physicians. Her research spans nephrology, biomineralization, and health informatics, with dual focus on kidney stone pathophysiology and health data communication. She investigates microbial entombment in urolithiasis, in vivo stone dissolution mechanisms, and develops visual hierarchies for health data. Additional interests include bedside art interventions for oncology patients and translational studies in diabetic gastroparesis, reflecting her commitment to patient-centered innovation. Publication analysis reveals three dominant research trajectories: (1) Geobiological studies of kidney stones (2018-2021) demonstrating microbial roles in biomineralization, (2) Health informatics work (2023-2024) addressing infodemics and data visualization, and (3) Clinical interventions (2014-2018) exploring pharmacological pathways and non-pharmacological therapies. Her work consistently bridges basic science with clinical applications in renal health and patient experience optimization.

Aron LukacherView profile

Professor

• Polyomavirus Infections
• T Cell Immunity
• Virology
• +3 more

Aron Lukacher is a Professor in the Department of Cell and Biological Systems and Department of Pathology and Laboratory Medicine at Penn State University. He holds affiliations with the Penn State Clinical and Translational Science Institute (CTSI), Penn State Cancer Institute, and One Health Microbiome Center, focusing on polyomavirus pathogenesis and immune responses. Research Focus: Polyomavirus infections, T cell immunity, immune evasion mechanisms, and organ-specific viral pathogenesis in the central nervous system and kidneys. Grants: Multiple NIH-funded projects including those from the National Institute of Neurological Disorders and Stroke and National Institute of Allergy and Infectious Diseases spanning 2012-2026. His recent work explores chemokine receptor interactions (e.g., CXCR4/CXCR6) in neuroinflammation, viral persistence in kidneys, and antiviral drug development (e.g., Brincidofovir). Articles highlight both basic virology and translational applications in clinical science. Labs/Teams: Collaborations with the Penn State Cancer Institute's Mechanisms of Carcinogenesis program and One Health Microbiome Center.

Maria José Serol de Brito CorreiaView profile

Associate Professor

• Microbiology
• Oral Microbiome
• Molecular Biology
• +3 more

Maria José Serol de Brito Correia serves as an Associate Professor at the Faculty of Dental Medicine of the Catholic University of Portugal (UCP) in Viseu, where she has been a faculty member since April 2001. She coordinates the first cycle of the Integrated Master's degree in Dental Medicine and teaches Molecular Genetics and Oral Microbiology courses. Her educational background includes: PhD in Biology (2001) from City University of New York (recognized by Universidade do Algarve in Biology, specialty of Microbiology) Master's degree in Biology (1996) from City University of New York Degree in Marine Biology and Fisheries (1994) from Universidade do Algarve Dr. Correia's research program focuses on the ecology of the human microbiome and its relationship with the host, with particular emphasis on salivary diagnostics. She has developed an extensive research portfolio examining the oral cavity as a diagnostic window for systemic conditions, including diabetes, cardiovascular disease, and autism spectrum disorders. Her work bridges basic microbiology with clinical applications, developing bioinformatic tools like OralCard and SalivaPRINT for analyzing oral biomarkers. She has established community-based research partnerships with the Senior Activity program of Viseu municipality and the Association for Developmental Disorders and Autism (APPDA)-Viseu, demonstrating her commitment to translational research that directly benefits local populations. Analysis of her publication record reveals a consistent research trajectory focused on oral microbiome characterization, salivary biomarker discovery, and computational approaches to oral health diagnostics. Her work spans fundamental microbiology studies of oral pathogens to clinical applications of salivary diagnostics, with increasing emphasis on bioinformatics tools for oral health assessment. The progression of her research shows movement from basic characterization of oral microorganisms toward sophisticated diagnostic applications using proteomics and computational biology. Dr. Correia is an active member of the Interdisciplinary Research Center in Health (CIIS) at UCP, where she contributes to the SalivaTec laboratory's mission of developing saliva-based diagnostic approaches. Her collaborative work extends across disciplines, connecting dental medicine with molecular biology, bioinformatics, and public health research.

Joel D. KaufmanView profile

Professor

• Environmental Health
• Occupational Medicine
• Air Pollution
• +4 more

Joel D. Kaufman is a Professor at the University of Washington School of Public Health with appointments in the Department of Environmental & Occupational Health Sciences, Medicine (General Internal Medicine), and Epidemiology. A physician-epidemiologist board-certified in internal and occupational medicine, he has been a full-time faculty member at UW since 1997. He serves as Director of the UW Center for Exposures, Diseases, Genomics and Environment at DEOHS and was named editor-in-chief of Environmental Health Perspectives in 2019. As an elected member of the US National Academy of Medicine, Dr. Kaufman is a leading researcher in environmental health sciences. Dr. Kaufman's research integrates epidemiology, exposure sciences, toxicology and clinical medicine, with primary focus on environmental factors in chronic diseases. His current research interests include environmental and occupational epidemiology, health effects of ambient and traffic-related air pollution, environmental factors in cardiovascular, respiratory and neurodegenerative diseases, and occupational asthma. He directs the UW Northlake Controlled Exposure Facility for experimental inhalation toxicology studies on health effects of combustion products, including diesel exhaust. Dr. Kaufman leads several major research projects including the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air), which has followed over 6,000 participants since 2000 to understand air pollution's relationship with cardiovascular disease. His publication record demonstrates consistent focus on air pollution health effects across multiple systems, with recent work examining connections between air pollution and neurological outcomes, cardiovascular disease, diabetes, mental health, and respiratory conditions. His research often employs sophisticated exposure assessment methods and large cohort studies. Editor-in-chief of Environmental Health Perspectives (2019-present) Elected member of the US National Academy of Medicine Director of the UW Center for Exposures, Diseases, Genomics and Environment Principal Investigator of MESA Air study As a mentor, Dr. Kaufman has guided numerous graduate students through the Environmental Health Assessment Program and Climate and Health Program. His advising spans environmental exposure assessment, air pollution health effects research, and epidemiological methods. He directs a specialized inhalation toxicology facility addressing health effects of traffic-derived air pollutants and has been featured extensively in national media discussing air pollution, wildfires, and climate-related health impacts.

Patricia DenningView profile

Adjunct Professor

• Intestinal Immunology
• Neonatal Gastroenterology
• Necrotizing Enterocolitis (NEC)
• +2 more

Patricia Denning is an Adjunct Professor at the Institute for Biomedical Sciences, Georgia State University, and an Assistant Professor in neonatal-perinatal medicine at Emory University. Her research focuses on understanding the developmental regulation of intestinal innate immunity and its role in necrotizing enterocolitis (NEC) in premature infants. Her educational background includes: M.D. from Baylor College of Medicine (1991-1995) Pediatric Residency at Baylor College of Medicine (1995-1997) and Boston University Medical School (1997-1998) Clinical Neonatology Fellowship and GI Research Fellowship at Harvard Medical School (1998-2002) Dr. Denning's research centers on how immature intestinal host defenses predispose premature infants to NEC. She investigates bacterial-host interactions and the role of normal bacterial colonization in maturing intestinal innate immune responses. Her work has significant implications for developing preventive strategies against NEC, a leading cause of neonatal morbidity and mortality. Analysis of her recent publications reveals a strong focus on the interplay between gut microbiota (particularly probiotics like Lactobacillus) and intestinal immunity in neonates. Key themes include the mechanisms by which commensal bacteria and probiotics enhance host defenses, prevent NEC, and regulate inflammatory and apoptotic pathways in the developing gut. Her research spans molecular, cellular, and clinical aspects of neonatal gastrointestinal diseases. While specific laboratory or team details are not provided in the text, her extensive publication record in high-impact journals indicates an active research program investigating the developmental biology of gut immunity and NEC pathogenesis.

• Addiction Medicine
• Lifestyle Medicine
• Disaster Psychiatry
• +3 more

Steven G. Sugden, MD, MPH, MSS, is Associate Professor (Clinical) of Psychiatry at the University of Utah, based at the Huntsman Mental Health Institute. He is board-certified in Psychiatry, Addiction Medicine, Disaster Medicine, and Lifestyle Medicine, and serves as Associate Training Director for the Addiction Psychiatry and Addiction Medicine Fellowships. Education: MD – University of Utah School of Medicine MPH – University of California, Berkeley MSS (Strategic Studies) – U.S. Army War College Residency in Psychiatry – University of California, Davis Medical Center BA in Spanish (minor Chemistry) – University of Utah Research Focus: Dr. Sugden’s scholarly work centers on integrating lifestyle interventions into psychiatric practice, with emphases on addiction medicine, disaster psychiatry, military/veteran mental health, and neuroplasticity in recovery. His publications explore connections between nutrition, the gut microbiome, and PTSD; lifestyle psychiatry pillars; and evidence-based strategies to enhance resilience and global mental health. Clinical & Academic Leadership: Beyond clinical practice, Dr. Sugden directs training programs for the next generation of addiction specialists, translates research into frontline care, and applies military medical insights to civilian disaster response. Board Certifications: American Board of Psychiatry and Neurology (Psychiatry) American Board of Addiction Medicine American Board of Disaster Medicine American Board of Lifestyle Medicine American Board of Preventive Medicine (Addiction Medicine) Professional Affiliations & Service: Colonel in the U.S. Army Reserves, with over a decade of experience in military and veteran healthcare systems. He has worked in residential, inpatient, private practice, and VA settings across Texas, North Carolina, and California before returning to Utah. Current Labs & Teams: Dr. Sugden is embedded within the Huntsman Mental Health Institute’s education and clinical teams, where he mentors fellows and residents in addiction and lifestyle psychiatry.

Pablo MarquetView profile

Professor

• Macroecology
• Theoretical Ecology
• Conservation Biology
• +7 more

Pablo Marquet is a Professor of Ecology at the Pontifical Catholic University of Chile, where he has served on faculty since 1994. He holds additional prominent roles as External Professor and Science Steering Committee member at the Santa Fe Institute (SFI), and President of the Instituto de Sistemas Complejos de Valparaíso (ISCV). His interdisciplinary work bridges ecology, anthropology, and complex systems theory. Marquet earned his Bachelor in Biology from Universidad de Concepción (Chile) in 1987 and Ph.D. in Biology from the University of New Mexico in 1993, followed by postdoctoral work at Pontificia Universidad Católica de Chile. His research spans macroecology, theoretical ecology, conservation, and global change with particular focus on scaling laws, metabolic theory, and climate change impacts. His lab investigates the emergence of biological complexity through multiple interconnected programs: scaling of abundance in communities, evolution of body size, metapopulation dynamics in changing landscapes, and the intersection of energy use with human social complexity. Recent work integrates cancer ecology with broader ecological theory, examining how stoichiometric niches drive metastatic processes. Analysis of his 2024-2025 publications reveals dominant themes in metabolic scaling across biological hierarchies (from cells to catchments), thermal response universality in biological systems, and urban metabolism applications. His work consistently applies network theory and power-law dynamics to biodiversity patterns in both natural and human-altered systems, with increasing emphasis on climate change resilience. Marquet's scientific recognition includes: Fellow of the Ecological Society of America Member of the Chilean Academy of Science Member of the National Academy of Sciences Member of the American Academy of Arts and Sciences Member of the World Academy of Sciences He actively mentors graduate students and leads collaborative initiatives including BioFI (Biodiversity Forecasting Initiative) and OcéanIA (AI for ocean-climate modeling). His research informs policy through contributions to the Earth Commission and IPBES-IPCC workshops, with specific focus on Latin American conservation challenges and Chilean sustainability strategies. Marquet directs research groups at both Pontifical Catholic University of Chile and ISCV, fostering interdisciplinary teams that combine mathematical modeling, field ecology, and anthropological perspectives. His SFI affiliation since the 1990s has been instrumental in developing complex systems approaches to ecological questions, particularly regarding the emergence of social complexity through cumulative cultural evolution.

Maren WellenreutherView profile

Professor

• Evolutionary Ecology
• Genomics
• Structural Genomic Variation
• +7 more

Maren Wellenreuther is a Professor at the School of Biological Sciences, University of Auckland, and Science Group Leader at Plant and Food Research, New Zealand. Her research integrates evolutionary ecology, genomics, and sustainable development with a focus on marine species adaptation and aquaculture optimization. Key interests include structural genomic variation, epigenetic mechanisms, and eco-evolutionary responses to climate change. PhD (University of Auckland, 2007) Docent (Lund University, 2014) Her work addresses critical societal challenges such as biodiversity conservation, sustainable seafood production, and climate resilience. Recent studies investigate chromosomal inversions in seaweed flies, genomic stock structure in snapper, and epigenetic drivers in aquaculture species. She has pioneered the use of long-read sequencing and SNP arrays for structural variant analysis. Notable scientific awards include: Thermo Fisher Scientific Award for Excellence in Molecular Biology (2020) Royal Society Te Apārangi Early Career Award (2018) Science New Zealand National Early Career Researcher Award (2017) KVA King Carl XVI Gustaf Scholarship (2013) Marian Cranwell Prize (2007) She has supervised 15+ PhD/MSc students and secured $11M+ in grants , including MBIE Endeavour Programme and Marsden Fund projects. Her leadership extends to editorial roles ( Evolutionary Applications ), advisory boards (TREE, Predator-Free 2050), and organizing international conferences on genomic applications in fisheries.

Iryna PinchukView profile

Professor

• Inflammatory Bowel Disease
• Cancer Immunology
• Mucosal Immunology
• +5 more

Dr. Iryna Pinchuk serves as a Professor in the Department of Medicine (Division of Gastroenterology and Hepatology) and the Department of Cell and Biological Systems at Penn State University, with significant contributions to the Penn State Cancer Institute's Mechanisms of Carcinogenesis program. Her dual appointments reflect an integrative approach bridging gastrointestinal immunology, cancer research, and stromal cell biology across institutional boundaries. Her pioneering research centers on mucosal immune dysregulation in inflammatory bowel disease (IBD) and gastrointestinal cancers, with landmark discoveries regarding CD90+ stromal cells (CMFs). She demonstrated CMFs' immunosuppressive role in maintaining mucosal tolerance under normal conditions and their pathological dysfunction in IBD and cancer. Current investigations focus on innate-adaptive immune crosstalk and microbiota-mediated modulation of these interactions, leveraging 15+ years of expertise in human/rodent mucosal immunology, cell biology, and microbiology. Recent publications (2024-2025) reveal dominant trends in targeting novel molecular pathways for IBD therapeutics, including MK2 inhibition, BRD4 epigenetic regulation, and NF-κB signaling modulation. These studies consistently employ translational approaches using animal models to dissect inflammation mechanisms, fibrosis development, and epithelial barrier integrity, with strong emphasis on clinical applicability for Crohn's disease and ulcerative colitis treatment. As Principal Investigator, Dr. Pinchuk leads active grants including U.S. Army and Congressionally Directed Medical Research Programs funding (2022-2026) for 'Targeting MK2 for Crohn's Disease,' alongside a completed NIDDK project (2014-2019) on CD90+ stromal cell regulation of Th1/Th17 responses. Her 77 publications and held patent demonstrate sustained research productivity, though specific student mentorship details remain unlisted in available materials. Her laboratory operates within the Penn State Cancer Institute ecosystem, directing a multidisciplinary team that integrates immunology, gastroenterology, and microbiology expertise. The research program utilizes advanced human tissue analysis and rodent models to investigate gastrointestinal mucosal immunity, with active collaborations spanning microbiome analysis, antimicrobial defense mechanisms, and stromal-immune interactions in disease pathogenesis.

Lily CheungView profile

Associate Professor

• Systems Biology
• Genetically Encoded Biosensors
• Quantitative Fluorescence Microscopy
• +8 more

Lily Cheung is an Associate Professor at the Georgia Institute of Technology , affiliated with the College of Engineering and the School of Chemical and Biomolecular Engineering . She is also the Roy C. and Polly B. Sheffield Faculty Fellow. Her work integrates computational methods with experimental approaches in plant biology, focusing on the interplay between metabolic and gene regulatory networks to advance agricultural biotechnology. BS, Chemical Engineering, Rutgers University, 2008 PhD, Chemical Engineering, Princeton University, 2013 Her research bridges systems biology, synthetic biology, and computational modeling to study plant physiology and development. She specializes in designing biomolecular sensors, quantitative fluorescence microscopy, and predictive models to decode how metabolic and genetic interactions govern plant growth. Lily’s publications emphasize systems-level approaches to plant biology, with recurring themes in gene regulatory networks , sugar transport , computational modeling , and plant-microbe interactions . Recent work (2025) applies hybrid modeling to lignin bioconversion, while earlier studies (2024-2015) explore transporter specificity, root microbiome dynamics, and developmental signaling. Scientific awards include: NSF NPGI Postdoctoral Fellowship in Biology NSF CAREER Award Human Frontier Science Program Early Career Award Lily’s lab develops quantitative tools for plant systems biology , with a focus on metabolic network interactions and predictive agricultural models . She previously held postdoctoral positions at the Carnegie Institution for Science and conducted foundational work at Rutgers University and Princeton University .

Adam D BaimView profile

Assistant Professor

• Neuro-Ophthalmology
• Adult Strabismus
• Medical Education
• +3 more

Adam D Baim serves as an Assistant Professor in the Department of Ophthalmology at Northwestern University's Feinberg School of Medicine, specializing in Neuro-Ophthalmology and adult strabismus. His clinical and academic work bridges surgical education, neuro-ophthalmic disorders, and microbiome research. His educational journey includes: BA from Wesleyan University (2008) MD and PhD from the University of Chicago (2018) Internal medicine/ophthalmology internship at Washington University in St. Louis (2019) Ophthalmology residency at Washington University in St. Louis (2022) Neuro-ophthalmology and adult strabismus fellowship at the University of Minnesota (2023) Dr. Baim's research integrates clinical neuro-ophthalmology with innovative medical education methodologies and ocular microbiome investigations. His work on surgical performance assessment pioneers narrative evaluation frameworks, while his microbiome research explores microbial contributions to inflammatory eye conditions. This dual focus demonstrates interdisciplinary rigor in translating basic science to clinical practice. Recent publications reveal evolving expertise: the 2025 surgical assessment study establishes explanatory feedback as a critical metric for educational quality, while 2019-2023 works solidify his neuro-ophthalmology leadership through conference proceedings and foundational microbiome analyses. Collectively, these contributions advance diagnostic precision and pedagogical standards in ophthalmology. Scientific awards: None reported in available documentation. Regarding academic mentorship and research funding, current disclosures indicate no active external professional relationships for 2024, suggesting primary institutional support for his scholarly activities without industry-sponsored grants. As a core faculty member in Northwestern Medicine's Neuro-Ophthalmology division, Dr. Baim participates in multidisciplinary clinical teams addressing complex visual pathway disorders while contributing to resident education through the Feinberg School of Medicine's ophthalmology training program.

Marie-Claire ArrietaView profile

Associate Professor

• Intestinal Microbiome
• Gut Microbiome
• Asthma
• +7 more

Marie-Claire Arrieta is an Associate Professor in the Departments of Physiology & Pharmacology and Pediatrics at the Cumming School of Medicine, University of Calgary. She leads the Arrieta Lab, which is part of the International Microbiome Center, focusing on the early-life microbiome in health and disease. Her research spans multiple clinical studies through the Alberta BLOOM initiative, which investigates microbiome development in premature and term infants. Dr. Arrieta's research interests center on microbial colonization beginning at birth and its impact on human health. Her lab investigates how the early-life microbiome communicates with developmental programming events necessary for a healthy start in life. Key research areas include asthma development, neurodevelopment and stress axis, metabolic syndrome and obesity, colonization resistance, and microbial ecology. She employs clinical and preclinical research approaches using Next Generation Sequencing, Metabolomics, and Immunological Profiling in both humans and animal models to decipher the role of bacterial and fungal microbiomes in chronic diseases. Her publication record shows a strong focus on the gut microbiome's role in childhood asthma, with significant contributions to understanding how early-life microbial exposure affects immune development. Recent work has expanded to include the fungal microbiome (mycobiome) and its implications for metabolic health and atopic diseases. Her research demonstrates how environmental factors such as birth method, feeding practices, and antibiotic use influence microbiome development and subsequent disease risk. Member of Health Inequality Network Life sciences discipline with focus on intestinal microbiome and asthma Author of public science communication materials including a published book and work on a children's book Active advocate for women in science Dr. Arrieta's work bridges clinical observation with mechanistic understanding, translating discoveries from human cohorts into animal models. Her Alberta BLOOM study follows premature infants from birth to three years, collecting comprehensive biological and clinical data to examine microbiome development. She has contributed to significant consensus statements including the ISAPP consensus on fermented foods and has participated in important discussions about methodological rigor in low-biomass microbiome studies.